Literature DB >> 20811350

Gene-environment interactions in Parkinson's disease: the importance of animal modeling.

M P Horowitz1, J T Greenamyre.   

Abstract

Parkinson's disease (PD), a late-onset neurodegenerative disorder, occurs most commonly in a "sporadic" (idiopathic) form, without a clearly defined genetic basis and only a vaguely delineated pathogenesis. Together, the various monogenic forms of PD (i.e., those arising from mutations in single genes) account for a minority of PD cases but have provided crucial insights into disease mechanisms. Although it is commonly believed that sporadic PD is caused by a lifetime of environmental exposures that are superimposed on an individual's composite genetic susceptibility, this hypothesis has not been tested adequately. This article reviews genetic and environmental factors that have been associated with PD and attempts to put these into a pathogenic framework. We argue that animal modeling will become increasingly important in attempting to elucidate gene-environment interactions, to define pathogenic mechanisms, and to provide a platform for testing of targeted therapeutic interventions.

Entities:  

Mesh:

Year:  2010        PMID: 20811350      PMCID: PMC3085510          DOI: 10.1038/clpt.2010.138

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  55 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  Pesticide exposure and self-reported Parkinson's disease in the agricultural health study.

Authors:  F Kamel; Cm Tanner; Dm Umbach; Ja Hoppin; McR Alavanja; A Blair; K Comyns; Sm Goldman; M Korell; Jw Langston; Gw Ross; Dp Sandler
Journal:  Am J Epidemiol       Date:  2006-11-20       Impact factor: 4.897

3.  Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.

Authors:  Erin H Norris; Kunihiro Uryu; Susan Leight; Benoit I Giasson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

4.  Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice.

Authors:  María Nieto; Francisco J Gil-Bea; Esther Dalfó; Mar Cuadrado; Felipe Cabodevilla; Belén Sánchez; Silvia Catena; Teresa Sesma; Elena Ribé; Isidro Ferrer; María J Ramírez; Teresa Gómez-Isla
Journal:  Neurobiol Aging       Date:  2005-07-11       Impact factor: 4.673

5.  Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.

Authors:  M J Casarejos; J Menéndez; R M Solano; J A Rodríguez-Navarro; J García de Yébenes; M A Mena
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

6.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.

Authors:  Ira E Clark; Mark W Dodson; Changan Jiang; Joseph H Cao; Jun R Huh; Jae Hong Seol; Soon Ji Yoo; Bruce A Hay; Ming Guo
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

7.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.

Authors:  Jeehye Park; Sung Bae Lee; Sungkyu Lee; Yongsung Kim; Saera Song; Sunhong Kim; Eunkyung Bae; Jaeseob Kim; Minho Shong; Jin-Man Kim; Jongkyeong Chung
Journal:  Nature       Date:  2006-05-03       Impact factor: 49.962

8.  LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.

Authors:  Shamol Saha; Maria D Guillily; Andrew Ferree; Joel Lanceta; Diane Chan; Joy Ghosh; Cindy H Hsu; Lilach Segal; Kesav Raghavan; Kunihiro Matsumoto; Naoki Hisamoto; Tomoki Kuwahara; Takeshi Iwatsubo; Landon Moore; Lee Goldstein; Mark Cookson; Benjamin Wolozin
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

9.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

10.  Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP.

Authors:  David D Song; Clifford W Shults; Abbyann Sisk; Edward Rockenstein; Eliezer Masliah
Journal:  Exp Neurol       Date:  2004-04       Impact factor: 5.330

View more
  37 in total

1.  Regulation of complex I by Engrailed is complex too.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

2.  Impairment of Atg5-dependent autophagic flux promotes paraquat- and MPP⁺-induced apoptosis but not rotenone or 6-hydroxydopamine toxicity.

Authors:  Aracely Garcia-Garcia; Annandurai Anandhan; Michaela Burns; Han Chen; You Zhou; Rodrigo Franco
Journal:  Toxicol Sci       Date:  2013-08-31       Impact factor: 4.849

3.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

Review 4.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

5.  Glutaredoxin 1 protects dopaminergic cells by increased protein glutathionylation in experimental Parkinson's disease.

Authors:  Humberto Rodriguez-Rocha; Aracely Garcia Garcia; Laura Zavala-Flores; Sumin Li; Nandakumar Madayiputhiya; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-09-14       Impact factor: 8.401

6.  Validation of hospital register-based diagnosis of Parkinson's disease.

Authors:  Lene Wermuth; Christina Funch Lassen; Liselotte Himmerslev; Jørgen Olsen; Beate Ritz
Journal:  Dan Med J       Date:  2012-03       Impact factor: 1.240

7.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

Review 8.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 9.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

10.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.